Reagent

UAE In-Vitro Fertilization Market: Growing Medical Tourism for Fertility Treatments Drives Sector - ResearchAndMarkets.com

Retrieved on: 
星期二, 十月 11, 2022
Health, Biotechnology, Lists of diseases, Physician, Edwards syndrome, Female, Infertility, Cholesterol, Vitamin D, Woman, Attention, Uterus, Family, Parent, CAGR, ART, Burqa, Chromosome, Obesity, Genetic disorder, AMH, Industry, NGS, Forecast, CCS, Application, Competition, Down syndrome, Awareness, Instrument, IVF, Reagent, Pregnancy, USD, Hormone, Medical device, Mineral oil, Tourism, Birth control

UAE In-Vitro Fertilization (IVF) market stood at USD 231.57 Million in 2021 and is expected to reach a CAGR of 9.64% during the forecast period.

Key Points: 
  • UAE In-Vitro Fertilization (IVF) market stood at USD 231.57 Million in 2021 and is expected to reach a CAGR of 9.64% during the forecast period.
  • UAE offers world class fertility treatment amalgamated with several other amenities such as gynecology consultation, diagnostic tests, etc.
  • As a result of which, most women in UAE face fertility issues because of deteriorated egg number and egg quality.
  • UAE In-Vitro Fertilization (IVF) Market, By Technique:
    UAE In-Vitro Fertilization (IVF) Market, By Reagent:

Global lmmunohistochemistry Reagents and Kits Market to Reach $3.53 Billion by 2027 at a CAGR of 5.92% - ResearchAndMarkets.com

Retrieved on: 
星期一, 十月 10, 2022
Health, Biotechnology, CAGR, Reagent, Patient, Hospital, Technology, Risk, Immunohistochemistry, Prevalence, Projection, Growth, USD, Incidence, Cancer, Health insurance, IHC

Global lmmunohistochemistry (IHC) Reagents and Kits Market is valued at USD 2.3 billion in 2021 and will rocket up to 3.53 billion by 2027 at a CAGR of 5.92% from 2022-2027.

Key Points: 
  • Global lmmunohistochemistry (IHC) Reagents and Kits Market is valued at USD 2.3 billion in 2021 and will rocket up to 3.53 billion by 2027 at a CAGR of 5.92% from 2022-2027.
  • The primary drivers promoting the growth of this market are the rising incidence and prevalence of cancer, technical advancements in IHC, and the accessibility of reimbursement for IHC testing.
  • Immunohistochemistry (IHC) market growth is fueled by a rise in diagnostic centres and hospitals as well as a surge in patients with serious illnesses.
  • During the projection period, this market's expansion is anticipated to be impeded by a high degree of consolidation among the key market participants.

Rare Biomarkers Specimen Collection and Stabilization Market to Reach USD 54.2 Billion, Globally, by 2031 at 8.7% CAGR: Allied Market Research

Retrieved on: 
星期五, 十月 7, 2022
Lists of diseases, Adoption, Spina bifida, Degenerative disease, Medicine, Hospital, Oncology, Prevalence, Growth, Chromosome, Neoplasm, Diagnosis, Infection, NIPT, CAGR, Chinese, Research, COVID-19, Investment, Collection, Coronavirus, Cystic fibrosis, Cancer, Genetic disorder, Technology, Precision medicine, Health, Prognosis, Transplant rejection, Lists of countries and territories, Reagent, DNA, Fetus, Biomarker, Muscular dystrophy, Leadership, Vaccine, Pharmaceutical industry, Medical imaging

PORTLAND, Ore., Oct. 7, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Rare Biomarkers Specimen Collection and Stabilization Market by Type (Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes Vesicles), by Product (Isolation Kits and Reagent, Blood Collection Tubes, Systems), by Application (Oncology, Cardiovascular Diseases, NIPT, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global rare biomarkers specimen collection and stabilization industry generated $23.3 billion in 2021, and is expected to reach $54.2 billion by 2031, witnessing a CAGR of 8.7% from 2022 to 2031.

Key Points: 
  • According to the report, the global rare biomarkers specimen collection and stabilization industry generated $23.3 billion in 2021, and is expected to reach $54.2 billion by 2031, witnessing a CAGR of 8.7% from 2022 to 2031.
  • However, the tedious and lengthy process for development of biomarkers and high cost of the development restrain the market growth.
  • The Covid-19 pandemic made a positive impact on the global rare biomarkers specimen collection and stabilization market, owing to surge in prevalence of rare diseases and innovations in diagnosis of diseases using biomarkers.
  • Rare biomarkers specimen collection and stabilization are utilized for determining what the coronavirus does to the body and how the body reacts on infection.

Outlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com

Retrieved on: 
星期四, 十月 6, 2022
Other Manufacturing, Manufacturing, Emotion, Reagent, Ansoff Matrix, Risk, Observation, Growth, SWOT, CAGR, Global, Porter's five forces analysis, Investment, Research, Software, Geography, Academic institution, SNP genotyping, Industry, Personal Software Services, Medication, Competitive analysis, Hospital, COVID-19, USD, Biotechnology, Market development, Retail, Marketing, Risk management, Medical device, Instrument

The "Global High-Resolution Melting Analysis Market (2022-2027) by Product, Applications, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global High-Resolution Melting Analysis Market (2022-2027) by Product, Applications, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The report presents a detailed Ansoff matrix analysis for the Global High-Resolution Melting Analysis Market.
  • The Global High-Resolution Melting Analysis Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global High-Resolution Melting Analysis Market.

Global Clinical Microbiology Instruments and Reagents Market Report 2022: Digitalization and Robotization Trend to Boost Sector - ResearchAndMarkets.com

Retrieved on: 
星期四, 九月 29, 2022
Research, Technology, Medical Devices, Infectious Diseases, Clinical Trials, Biotechnology, Pharmaceutical, Robotics, Health, Science, Time, Laboratory, Efficiency, COVID-19, Prevalence, Vertically transmitted infection, Method, Research, Medicine, Microbiology, Infection, STD, Reagent, CAGR, Medical device, Pet

The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Clinical microbiology holds a prominent role in the field of research and medicine, and support the fight against numerous infectious diseases along with antimicrobial resistance.
  • The uptake of microbiology is further favored by technological advancements including automated instruments to identify pathogens across laboratories.
  • The U.S. Market is Estimated at $1.7 Billion in 2022, While China is Forecast to Reach $284.1 Million by 2026
    The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.7 Billion in the year 2022.

United States In Vitro Diagnostics Markets Report 2022-2030 Featuring Key Players - QIAGEN; F. Hoffman-La Roche; Thermo Fisher Scientific; Danaher; Illumina - ResearchAndMarkets.com

Retrieved on: 
星期二, 九月 6, 2022
Diabetes, Pharmaceutical, Managed Care, Oncology, Biometrics, Medical Devices, Infectious Diseases, Neurology, Hospitals, Genetics, Cardiology, Biotechnology, Science, Other Science, Research, Health, QIAGEN, Danaher Corporation, CVD, COVID-19, Patient, University, Application, Degenerative disease, CDC, Ageing, Death, Lists of diseases, Genetic testing, Molecular diagnostics, Tissue, USD, Infection, Medicine, Blood, Point-of-care testing, Physician, Immunoassay, Diagnosis, IVD, POC, Center, Cardiovascular disease, Urine, Prevalence, FDA, CAGR, Population, Korea Disease Control and Prevention Agency, University of California, San Francisco, Genomics, Industry, Proteomics, Adoption, Reagent, Efficiency, Medical device, Vaccine, Pharmaceutical industry, Technology, Illumina

In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments, Services), by Technology (Immunoassay, Molecular Diagnostics), by Application, by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments, Services), by Technology (Immunoassay, Molecular Diagnostics), by Application, by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. in vitro diagnostics market size is expected to reach USD 36.56 billion by 2030.
  • Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD).
  • The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

In Vitro Diagnostics Market Size Worth $113.38 Billion by 2030 - Grand View Research, Inc.

Retrieved on: 
星期一, 九月 5, 2022
Partnership, Reagent, CVD, COVID-19, Technology, Cancer, Application, SAN, Genetic testing, USD, Infection, Diagnosis, Degenerative disease, POC, Severe acute respiratory syndrome coronavirus 2, PCR, Prevalence, CAGR, Hospital, Instrument, Adoption, Nature, Pharmaceutical industry, Medical device, Cryptocurrency, Texas Homecare

SAN FRANCISCO, Sept. 5, 2022 /PRNewswire/ -- The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Sept. 5, 2022 /PRNewswire/ -- The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc.
  • Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers.
  • Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.
  • Read 200-page market research report, " In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Test Location (PoC, Homecare), By End-use (Hospitals, Laboratory), By Application, By Technology, And Segment Forecasts, 2022 - 2030 ", published by Grand View Research.

Ansa Biotechnologies Expands Leadership Team with Appointment of Jeremiah Hanes, Ph.D. as Senior Vice President of R&D

Retrieved on: 
星期二, 八月 23, 2022
Biotechnology, Technology, Other Health, Health, Pharmaceutical, Biometrics, Other Science, Research, Nanotechnology, Genetics, Science, Enzyme, CEO, Technology, Synthetic biology, Research and development, Research, Abraxis BioScience, University of Nebraska–Lincoln, R, Hanes, SVP, University, LinkedIn, DNA, 1996-10-24 Frank Erwin Center, University of Texas, Austin, TX, Method, Chemical biology, Cornell University, Ansa, Twitter, Biotechnology, Genomics, Reagent, Management, Fine chemical, Biochemistry

Ansa Biotechnologies , today announced the appointment of Jeremiah Hanes, Ph.D., as Senior Vice President (SVP) of Research & Development (R&D).

Key Points: 
  • Ansa Biotechnologies , today announced the appointment of Jeremiah Hanes, Ph.D., as Senior Vice President (SVP) of Research & Development (R&D).
  • He joins Ansas Senior Executive Team and will be responsible for the advancement of all research and development activities.
  • Dr. Hanes joins Ansa from PacBio, a leading developer of highly accurate and comprehensive DNA sequencing technologies, where he was most recently Vice President of Reagents R&D.
  • Ansa Biotechnologies is building a fast and reliable DNA synthesis service to accelerate synthetic biology research.

Veterinary Ultrasound Market worth $449 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期五, 八月 5, 2022
Knowledge, Hospital, Intelligence, SME, 3D, Population, Technology, Growth, Fujifilm, Pregnancy, CT, Cardiology, GE Healthcare, Efficiency, Research, Obstetrics, Pet, Doppler effect, Review, 2D, GEM, Small, Urbanization, Radiology, Awareness, CAGR, Elective surgery, Journal of Psychosomatic Obstetrics & Gynecology, Orthopedic surgery, Sports medicine, Digital, CR, Animal, MRI, Overalls, Ultrasound, USD, Medical imaging, Marketing, Software, Reagent, Gynaecology, Dentistry

CHICAGO, Aug. 5, 2022 /PRNewswire/ -- Veterinary Ultrasound Market is projected to grow from USD 334 million in 2022 to USD 449 million by 2027, at a CAGR of 6.1% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Aug. 5, 2022 /PRNewswire/ -- Veterinary Ultrasound Market is projected to grow from USD 334 million in 2022 to USD 449 million by 2027, at a CAGR of 6.1% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • On the basis of type, the animal ultrasound market is segmented into 2D ultrasound, 3D/4D ultrasound, and Doppler ultrasound.
  • Based on product, the veterinary ultrasound market is segmented into cart-based and portable ultrasound scanners.
  • Based on end user, the animal ultrasound market is segmented into veterinary clinics, veterinary hospitals and academic institutes, as well as other end users.

Veterinary Ultrasound Market worth $449 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期五, 八月 5, 2022
Knowledge, Hospital, Intelligence, SME, 3D, Population, Technology, Growth, Fujifilm, Pregnancy, CT, Cardiology, GE Healthcare, Efficiency, Research, Obstetrics, Pet, Doppler effect, Review, 2D, GEM, Small, Urbanization, Radiology, Awareness, CAGR, Elective surgery, Journal of Psychosomatic Obstetrics & Gynecology, Orthopedic surgery, Sports medicine, Digital, CR, Animal, MRI, Overalls, Ultrasound, USD, Medical imaging, Marketing, Software, Reagent, Gynaecology, Dentistry

CHICAGO, Aug. 5, 2022 /PRNewswire/ -- Veterinary Ultrasound Market is projected to grow from USD 334 million in 2022 to USD 449 million by 2027, at a CAGR of 6.1% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Aug. 5, 2022 /PRNewswire/ -- Veterinary Ultrasound Market is projected to grow from USD 334 million in 2022 to USD 449 million by 2027, at a CAGR of 6.1% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • On the basis of type, the animal ultrasound market is segmented into 2D ultrasound, 3D/4D ultrasound, and Doppler ultrasound.
  • Based on product, the veterinary ultrasound market is segmented into cart-based and portable ultrasound scanners.
  • Based on end user, the animal ultrasound market is segmented into veterinary clinics, veterinary hospitals and academic institutes, as well as other end users.